Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | flavodoxin | 0.0169 | 0.3504 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0441 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0441 | 1 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0169 | 0.3504 | 0.2654 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.005 | 0.0676 | 0.5 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.005 | 0.0676 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.005 | 0.0676 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0441 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0219 | 0.47 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0272 | 0.5976 | 0.5976 |
Schistosoma mansoni | NADH-cytochrome B5 reductase | 0.005 | 0.0676 | 0.0676 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0169 | 0.3504 | 0.3033 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0169 | 0.3504 | 0.2654 |
Schistosoma mansoni | cytochrome B5 | 0.005 | 0.0676 | 0.0676 |
Echinococcus multilocularis | cytochrome b5 reductase 4 | 0.005 | 0.0676 | 0.0676 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0219 | 0.47 | 1 |
Mycobacterium tuberculosis | Possible oxygenase | 0.005 | 0.0676 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0391 | 0.8804 | 1 |
Loa Loa (eye worm) | diaphorase | 0.005 | 0.0676 | 0.0676 |
Echinococcus granulosus | methionine synthase reductase | 0.0272 | 0.5976 | 0.5976 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.005 | 0.0676 | 0.0676 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.005 | 0.0676 | 0.0676 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.005 | 0.0676 | 0.0676 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0441 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0441 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0082 | 0.1441 | 0.1441 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.005 | 0.0676 | 0.0676 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0441 | 1 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0441 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0272 | 0.5976 | 0.5976 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0169 | 0.3504 | 0.3033 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.005 | 0.0676 | 0.5 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0075 | 0.1276 | 0.1276 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0219 | 0.47 | 0.47 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0169 | 0.3504 | 0.3033 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0441 | 1 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0391 | 0.8804 | 0.8717 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0075 | 0.1276 | 0.1276 |
Plasmodium vivax | hypothetical protein, conserved | 0.0169 | 0.3504 | 0.3033 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0169 | 0.3504 | 0.2654 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0441 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0169 | 0.3504 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0169 | 0.3504 | 0.5 |
Brugia malayi | diaphorase | 0.005 | 0.0676 | 0.0676 |
Onchocerca volvulus | 0.005 | 0.0676 | 0.5 | |
Echinococcus multilocularis | methionine synthase reductase | 0.0272 | 0.5976 | 0.5976 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0169 | 0.3504 | 0.2654 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0169 | 0.3504 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0082 | 0.1441 | 0.1441 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0441 | 1 | 1 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0169 | 0.3504 | 0.3033 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0169 | 0.3504 | 0.3033 |
Loa Loa (eye worm) | hypothetical protein | 0.0441 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0441 | 1 | 1 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0075 | 0.1276 | 0.1276 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0169 | 0.3504 | 0.3504 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0441 | 1 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0441 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0441 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0441 | 1 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0391 | 0.8804 | 0.8647 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.1038 | 0.1038 |
Leishmania major | cytochrome P450 reductase, putative | 0.0391 | 0.8804 | 0.8717 |
Echinococcus multilocularis | NADH cytochrome b5 reductase 3 | 0.005 | 0.0676 | 0.0676 |
Leishmania major | p450 reductase, putative | 0.0441 | 1 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0075 | 0.1276 | 0.1276 |
Brugia malayi | FAD binding domain containing protein | 0.0272 | 0.5976 | 0.5976 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0169 | 0.3504 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0441 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0169 | 0.3504 | 0.3033 |
Brugia malayi | FAD binding domain containing protein | 0.0441 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0169 | 0.3504 | 0.5 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0441 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0391 | 0.8804 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0272 | 0.5976 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0222 | 0.478 | 0.478 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0441 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0441 | 1 | 1 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0169 | 0.3504 | 0.3033 |
Echinococcus granulosus | NADH cytochrome b5 reductase 3 | 0.005 | 0.0676 | 0.0676 |
Brugia malayi | flavodoxin family protein | 0.0169 | 0.3504 | 0.3504 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 39.04 uM | PUBCHEM_BIOASSAY: Antifungal Drug Resistance - Mammalian Cell Toxicity Measured in Cell-Based System Using Plate Reader - 2037-04_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2007] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.